Mehmet B Yilmaz Selected Research

Mehmet B Yilmaz Research Topics

12	Heart Failure 01/2022 - 12/2013
4	Atrial Fibrillation 01/2022 - 09/2004
2	Heart Diseases (Heart Disease) 01/2022 - 01/2018
2	Myocardial Infarction 01/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2019 - 05/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Sudden Death 12/2021
1	Systolic Heart Failure 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Chest Pain (Chest Pains) 01/2020
1	Acute Coronary Syndrome 01/2020
1	Dyspnea (Shortness of Breath) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2018
1	Atherosclerosis 04/2018
1	Sepsis (Septicemia) 12/2013
1	Melanoma (Melanoma, Malignant) 10/2008
1	Atrial Heart Septal Defects (Atrial Septal Defect) 09/2004

6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2018
5	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2021 - 01/2016
4	Natriuretic PeptidesIBA 01/2022 - 01/2019
3	Cardiac MyosinsIBA 01/2022 - 11/2020
3	omecamtiv mecarbilIBA 01/2022 - 11/2020
3	Neprilysin (Neutral Endopeptidase)IBA 12/2021 - 01/2018
3	Valsartan (Vals)FDA Link 12/2021 - 01/2018
3	paragonIBA 12/2021 - 01/2018
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 12/2021 - 01/2018
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021 - 01/2018
2	DiureticsIBA 01/2021 - 01/2018
2	Simendan (Levosimendan)IBA 11/2019 - 12/2013
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	UlaritideIBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	Blood Glucose (Blood Sugar)IBA 05/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2018
1	apelin-13 peptideIBA 04/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015
1	Potassium Channels (Potassium Channel)IBA 12/2013
1	CalciumIBA 12/2013
1	Muramidase (Lysozyme)IBA 10/2008
1	Atrial Natriuretic Factor (ANF)IBA 09/2004

5	Therapeutics 01/2021 - 11/2019
1	Length of Stay 01/2019
1	Intravenous Infusions 01/2019
1	Patient Readmission 01/2019
1	Renal Dialysis (Hemodialysis) 04/2018